15
Participants
Start Date
April 8, 2021
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Larotrectinib
"1. Larotrectinib monotherapy x2 cycles followed by disease evaluation~2. Larotrectinib with or without chemotherapy backbone"
Larotrectinib surgical
"1. Surgical cohort: Larotrectinib x 3-5 days prior to definitive surgery followed by Larotrectinib monotherapy x2 cycles followed by disease evaluation~2. Larotrectinib with or without chemotherapy backbone"
RECRUITING
Sydney Children's Hospital, Randwick
RECRUITING
Queensland Children's Hospital, South Brisbane
RECRUITING
Perth Children's Hospital, Perth
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Children's National Medical Center, Washington D.C.
RECRUITING
Duke University Health System, Durham
RECRUITING
Nationwide Children's Hospital, Columbus
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
NOT_YET_RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), Heidelberg
RECRUITING
Texas Children's Hospital, Houston
RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
Seattle Children's Hospital, Seattle
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
The Hospital for Sick Children (SickKids), Toronto
RECRUITING
Montreal Children's Hospital, Montreal
RECRUITING
University Medical Center Augsburg, Augsburg
RECRUITING
University Hospital Berlin, Berlin
RECRUITING
University Hospital Koln, Cologne
RECRUITING
University Medical Center Gottingen, Göttingen
Nationwide Children's Hospital
OTHER